Articles Tagged With:
-
Antithrombotic Treatment for Atrial Fibrillation After Acute Coronary Events
An analysis of the AUGUSTUS trial comparing a P2Y12 inhibitor plus four combinations of double or triple therapy with apixaban, aspirin, and a vitamin K antagonist in patients with atrial fibrillation and a recent acute coronary event or percutaneous coronary intervention has shown that a P2Y12 inhibitor plus apixaban exhibited the lowest rate of major adverse events and major bleeding events.
-
Screening for Atrial Fibrillation in Older Adults
A two-week ambulatory electrocardiogram monitor in a large group of individuals 70 years of age or older with no history of atrial fibrillation (AF) showed a very low incidence of AF (4.4%), almost all of which was paroxysmal. In less than 2% of the subjects did it represent ≥ 2% of the monitoring time. However, some patients had hours of AF, raising a concern for thromboembolic risk.
-
A New Drug for Heart Failure with Preserved Ejection Fraction?
The addition of the nonsteroidal mineralocorticoid receptor antagonist finerenone to standard therapy reduced the incidence of recurrent heart failure and death compared to placebo in patients with heart failure and mildly reduced or preserved left ventricular ejection fraction and was generally well tolerated.
-
Early Bird or Night Owl: Who’s Mentally Sharper?
A large cross-sectional analysis of adults aged 53-86 years found that people with normal sleep durations while being “night owls” often scored higher on cognitive tests than “early bird” types.
-
Evaluation and Management of Anaphylaxis in the Emergency Department
This article will present the most current information for diagnosing allergic reactions and anaphylaxis and how to treat them properly.
-
Eat Your Fruits and Veggies to Decrease HPV Infection
The authors of a study theorized that the increase in vitamin C and other immunological benefits of a regular diet including dark green vegetables and beans and fruits may reduce inflammation and enhance the immune system response, facilitating clearance of genital human papillomavirus.
-
Immediate vs. Delayed Postpartum Long-Acting Reversible Contraception
Administering long-acting reversible contraceptives before hospital discharge reduced pregnancy risk and increased usage at six months, making it an effective option for postpartum contraception.
-
Are Deep Contraceptive Implant Removals Predictable?
In this retrospective cohort study of 747 patients undergoing contraceptive implant removal, lower body mass index at insertion, weight gain during use, and longer duration of use were risk factors for deep contraceptive implant removal procedures.
-
HPV Vaccination Disparities Among Adult Women in the United States
A longitudinal, cross-sectional cohort study of 113,344 participants demonstrated that lack of health insurance, lack of stable employment, and lower income were significantly associated with decreased human papillomavirus vaccination uptake in women aged 18-47 years residing in the United States.
-
Doxy-PEP Could Be Prevention Strategy for Some Patients
Post-exposure prophylaxis (PEP) of doxycycline is recommended by the Centers for Disease Control and Prevention (CDC) for prevention of chlamydia, syphilis, and gonorrhea infections for men who have sex with men (MSM) and transgender women who have had a bacterial sexually transmitted infection (STI) within the past year, according to a new paper on doxycycline-PEP. But it also is a strategy that may work well for cisgender women who have a similar risk profile.